Wasim Malik

Overview

Wasim Malik is a seasoned venture capital investor and advisor specializing in deep tech and biotech sectors. As the Managing Partner at Iaso Ventures, he oversees the firm's strategy, investments, and partnerships, focusing on early-stage investments and new venture creation at the intersection of technology and life sciences. Prior to this, he served as the Chief Digital Strategist at Roivant Sciences, where he led digital health investments, strategy, and partnerships to accelerate drug development and commercialization across multiple therapeutic areas. Additionally, Malik has held key roles at prestigious institutions like Harvard Medical School and Massachusetts General Hospital, where he built a research program on tech-enabled clinical research in neurology. He has also served on the board of directors at companies such as Saphetor and Altimate Health, and on the business advisory board of the Epilepsy Foundation. Malik holds a Ph.D. in electrical engineering from the University of Oxford, postdoctoral training in neuroscience from MIT, and executive education in venture capital and private equity from Harvard Business School. His diverse background and extensive experience make him a prominent figure in the venture capital landscape, particularly in the deep tech and biotech sectors. Malik's investment focus includes deep tech, biotech, artificial intelligence, healthcare, digital health, therapeutics, and pharmaceuticals. He has a track record of investing in early-stage companies, with investment sizes typically ranging from $1 million to $5 million. His geographical focus spans the United States, United Kingdom, and Pakistan, reflecting his global perspective and commitment to fostering innovation across different regions. His strategic approach combines scientific expertise with industry connections, enabling him to identify and support promising startups in the healthcare and life sciences sectors. Through his leadership at Iaso Ventures and previous roles, Malik has demonstrated a strong commitment to advancing healthcare and technology through strategic investments and partnerships. His work continues to influence the development of innovative solutions in the biotech and deep tech industries, contributing to the growth and success of numerous startups in these fields.

Investment Focus

• Innovative solutions in deep tech and biotech sectors
• Strong management teams
• Scalable business models
• Potential for significant impact in healthcare and life sciences

Portfolio Companies